NZYM B Novozymes A/S Class B

Election of employee representatives to the Board of Directors

Election of employee representatives to the Board of Directors

The employees  have conducted the election of employee representatives to the Board of Directors of Novonesis (Novozymes A/S).

The following employee representatives (in alphabetical order after surname) were elected for the next four years:

  • Robert Nøddeskov Jensen, Senior Operator - newly elected
  • Lars Bo Køppler, Technician - newly elected
  • Preben Nielsen, Science Manager – re-elected
  • Frederikke Rose Spenner, Production Engineer - newly elected

As alternates to the employee representatives to the Board of Directors, the employees elected Mikael Barfred, Heidi Gelt and Ida Carlsen Virklund (listed in alphabetical order after surname).

As re-elected, Preben Nielsen will continue in the Board of Directors, and the newly elected employee representatives will join the Board of Directors following the Annual General Meeting of Novonesis on April 3, 2025. At the same event, the term of election for the former employee representatives, Lena Bech Holskov, Anders Hentze Knudsen, and Jens Øbro will end.

The term of Board Observer Kim Ib Sørensen will also end following the Annual General Meeting of Novonesis on April 3, 2025.

Attachment



EN
05/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Novozymes A/S Class B

 PRESS RELEASE

Novonesis completes acquisition of dsm-firmenichs’s share of the Feed ...

Novonesis completes acquisition of dsm-firmenichs’s share of the Feed Enzyme Alliance Novonesis has successfully completed the acquisition of dsm-firmenich’s share of the Feed Enzyme Alliance following the satisfaction of all closing conditions. The acquisition was initially announced on February 11, 2025 (announcement No 2). Please read the full announcement in PDF. Attachment

 PRESS RELEASE

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

 PRESS RELEASE

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

 PRESS RELEASE

Combining EVP roles of Human Health Biosolutions and Strategy & Integr...

Combining EVP roles of Human Health Biosolutions and Strategy & Integration As a next step on Novonesis’ integration journey, we combine the two EVP areas Human Health Biosolutions and Strategy & Integration.  COPENHAGEN, Denmark – After successfully combining into one company, Novonesis is delivering strong results, progressing firmly on the integration, as well as realizing synergies across the company. As a next step on our integration journey, the EVP area of Strategy & Integration will combine with the Human Health Biosolutions sales area. Henrik Joerck Nielsen, currently Executive Vi...

 PRESS RELEASE

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

ResearchPool Subscriptions

Get the most out of your insights

Get in touch